Home

helps physicians and healthcare professionals

Erectile Dysfunction

helps physicians and healthcare professionals

Doctor123.org

helps physicians and healthcare professionals

Cavernous Sinus Thrombosis, Emergency Medicine


Basics


Description


  • Thrombosis of a branch of the major intracerebral venous drainage system
  • Most commonly infectious
  • Spreads from facial, odontogenic, or sinus infection
  • Less frequently occurs with hypercoagulable state

Anatomy
3 primary sites of thrombosis:  
  • Cavernous sinus-Most common:
    • Drainage from superficial venous system
  • Superolateral to the sphenoid sinus and surrounds the sella:
    • Cranial nerves (CN) III, IV, V1, and V2 traverse the lateral wall of the sinus.
    • CN VI and the internal carotid artery occupy the medial portion of the sinus.
  • Can also involve transverse sinus and superficial sagittal sinus

Pathophysiology
  • Hematogenous spread of facial, otic, or neck infection into venous drainage system
  • Contiguous spread directly from infected sinus cavities (sphenoid, ethmoid > frontal)
  • Bacterial overgrowth leads to inflammation and coagulation, resulting in thrombosis.
  • Venous engorgement of cavernous sinus can affect adjacent structures:
    • Ophthalmoplegia from inflammation of CN III, IV, or VI
    • Pupillary fixation from CN III
    • Sensory deficits or paresthesia of forehead or cheek from CN V1 and V2

Etiology


  • Septic:
    • Staphylococcus aureus accounts for 70%
    • Streptococcus pneumoniae, gram-negative bacilli, and anaerobes also seen
    • Fungi less common; include Aspergillus and Rhizopus species
  • Aseptic:
    • Less common
    • Granulomatous conditions (TB)
    • Inflammatory disorders
    • From mass effect (tumors at base of skull, aneurysms)
  • Hypercoagulable states

  • Children may present with nonspecific symptoms such as decreased energy, vomiting, fever.
  • Have high level of suspicion for any child with recent otitis or pharyngitis with worsening symptoms, declining mental status, or signs of increased intracranial pressure (ICP):
    • HTN, bradycardia, lethargy, vomiting, gait instability
  • More common in the neonatal period, when diagnosis can be extremely difficult to make

Diagnosis


Signs and Symptoms


  • Symptoms:
    • Headache occurs in 90% of patients.
    • Fever
    • Ocular or retrobulbar pain
    • Facial swelling
    • Visual disturbance
    • Facial dysesthesia
    • Lethargy or altered mental status
  • Signs:
    • Periorbital edema is earliest sign
    • Chemosis with retinal vein engorgement
    • Ptosis, proptosis
    • Ophthalmoplegia
    • CN palsies:
      • Lateral gaze palsy (CN VI)
      • Hypo/hyperesthesia of V1 and V2 (CN V)
    • Meningismus
    • Altered level of consciousness or coma
    • Seizures
    • Sepsis with cardiovascular instability or collapse

History
High-risk historical factors include:  
  • A history of trauma
  • Previous ear/nose/throat (ENT) or neurosurgical instrumentation
  • History of central face furuncle that was manipulated
  • Diabetes or immunocompromised state (HIV, steroid use, cancer) may increase risk

Essential Workup


  • Clinical diagnosis: Venous engorgement, ocular symptoms, unilateral symptoms that become bilateral, rapidly progressive
  • Labs nonspecific
  • Imaging findings can be subtle

Diagnosis Tests & Interpretation


Lab
  • Neither sensitive nor specific
  • CBC:
    • Leukocytosis
    • Bandemia
  • PT/PTT/INR
  • ESR and D-dimer usually elevated
  • Lumbar puncture/CSF: Parameningeal inflammation or frank mengingitis

Imaging
  • CT scan:
    • Can be normal early in disease course
    • Noncontrast can show increased density
    • Contrast can show filling defect
      • May identify original source of infection (e.g., sinusitis)
      • Dilated superior ophthalmic vein
      • Associated intracranial hemorrhage
      • Signs of increased ICP: Small ventricles, loss of sulci
  • MRI with MR angiography (MRA)/MR venography (MRV):
    • Diagnostic modality of choice
    • Direct visualization of intracranial vessels and sinuses
    • Capable of visualizing thrombus at any stage

Differential Diagnosis


  • Meningitis/encephalitis
  • Intracranial abscess
  • Periorbital and orbital cellulitis
  • Internal carotid artery aneurysm or fistula
  • Pseudotumor cerebri
  • Acute angle-closure glaucoma
  • Intracranial hemorrhage
  • Tolosa-Hunt syndrome: Rare granulomatous inflammation of cavernous sinus

  • Extremely difficult diagnosis to make.
  • Maintain a high level of suspicion in toxic-appearing patients with recent ENT infections or in patients with refractory headache and risk factors for hypercoagulability or intracranial infection.

Treatment


Pre-Hospital


  • Patients can be altered and unstable.
  • May require rapid assessment and stabilization of airway, breathing, and circulation (ABCs)

Initial Stabilization/Therapy


  • Careful assessment of mental status with intubation for airway protection as needed
  • Aggressive fluid resuscitation for cardiovascular instability

Ed Treatment/Procedures


  • Broad-spectrum antibiotics with multiple drug regimens:
    • Cover for gram positives, gram negatives, as well as anaerobes.
    • Nafcillin or vancomycin (for methicillin-resistant S. aureus [MRSA]) + ceftriaxone:
      • Add metronidazole or clindamycin in significant infections.
  • Heparin:
    • Attenuates clot propagation and decreases morbidity/mortality.
    • Controversial in transverse and sagittal thrombosis owing to higher risk of subsequent hemorrhage
    • Administer only after ruling out bleed on CT scan.
    • Questionable superiority of LMWH over IV heparin
    • Endovascular TPA in severe refractory cases
  • Systemic steroids:
    • Believed to be of benefit with concomitant pituitary insufficiency, and with infectious or inflammatory etiologies
  • Appropriate management of increased ICP as needed
  • Surgical consultation for drainage of primary site of infection (e.g., dental abscess or sinusitis)

Medication


  • Ceftriaxone: 2 g/d IV (peds: 80-100 mg/kg/d to q12h)
  • Clindamycin: 300-900 mg IV q6-12h (neonates: 10-20 mg/kg/24h IV divided q6-12h; peds: 25-40 mg/kg/24h divided q6-8h)
  • Metronidazole: 500 mg IV q6h (neonates: 7.5-30 mg/kg/24h IV divided q12-24h; peds: 30 mg/kg/24h IV divided q6h)
  • Nafcillin: 1-2 g IV q4h (peds: 50-75 mg/kg/24h IV divided q8-12h depending on age)
  • Vancomycin: 1 g IV q12h (peds: 10-20 mg/kg IV q8-12h depending on age)

First Line
  • Broad-spectrum antibiotics
  • Anticoagulation

Second Line
  • Dexamethasone or hydrocortisone IV
  • Endovascular thrombolytics in selected cases

Follow-Up


Disposition


Admission Criteria
  • All patients with sinus thrombosis warrant admission to a monitored setting.
  • Consider ICU admission.

Discharge Criteria
None  

Followup Recommendations


Neurologic and neurosurgical consultation  

Complications


  • Blindness
    • 1/6 left with visual impairment
  • CN palsies
  • Meningitis or intracranial abscess
  • Seizures, especially in superior sagittal sinus thrombosis
  • Pituitary necrosis and insufficiency from local invasion
  • Septic emboli
  • Sepsis and shock
  • 30% mortality

Pearls and Pitfalls


  • Diagnosis is made on clinical evaluation and confirmatory lab evidence. Maintain a high index of suspicion.
  • Noncontrast head CT is often negative or nonspecific. MRI/MRV is the diagnostic imaging modality of choice and should be pursued in high-risk individuals.
  • Administer IV antibiotics early, especially in any ill-appearing patient with ENT or neurologic complaints.
  • Hypercoagulable states result in both central and peripheral venous thrombosis. Workup and management decisions must include consideration of systemic thromboembolism.

Additional Reading


  • Cannon  ML, Antonio  BL, McCloskey  JJ, et al. Cavernous sinus thrombosis complicating sinusitis. Pediatr Crit Care Med.  2004;5(1):86-88.
  • Carvalho  KS, Garg  BP. Cerebral venous thrombosis and venous malformations in children. Neurol Clin North Am.  2002;20:1061-1077.
  • Laupland  KB. Vascular and parameningeal infections of the head and neck. Infect Dis Clin North Am.  2007;21(2):577-590, viii.
  • Misra  UK, Kalita  J, Bansal  V. D-dimer is useful in the diagnosis of cortical venous sinus thrombosis. Neurol India.  2009;57(1):50-54.
  • Sztajunkrycer  M, Jauch  EC. The difficult diagnosis: Unusual headaches. Emerg Med Clin North Am.  1998;16(4):741-760.

See Also (Topic, Algorithm, Electronic Media Element)


Headache  

Codes


ICD9


  • 325 Phlebitis and thrombophlebitis of intracranial venous sinuses
  • 437.6 Nonpyogenic thrombosis of intracranial venous sinus

ICD10


  • G08 Intracranial and intraspinal phlebitis and thrombophlebitis
  • I67.6 Nonpyogenic thrombosis of intracranial venous system

SNOMED


  • 89980009 Thrombosis of cavernous venous sinus
  • 192770001 Thrombophlebitis of cavernous sinus (disorder)
  • 302879007 Septic thrombophlebitis of cavernous sinus
  • 95794005 Tolosa-Hunt syndrome
Copyright © 2016 - 2017
Doctor123.org | Disclaimer